Bronchoalveolar lavage

Progress in Respiratory Research

Volumn 36, Issue , 2007, Pages 58-67

  Drent, M ^a   Baughman, R ^b   Meyer, K ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449086905     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000102626     Document Type: Review

References (56)

1. Baughman RP, Drent M: Role of bronchoalveolar lavage in interstital lung disease. Clin Chest Med 2001;22:331-341.
2. Reynolds HY: Diagnostic and management strategies for diffuse interstitial lung disease. Chest 1998;113:192-202.
3. Meyer KC: The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2004;25:637-649.
4. Kilinc G, Kolsuk EA: The role of bronchoalveolar lavage in diffuse parenchymal lung diseases. Curr Opin Pulm Med 2005;11:417-421.
5. Klech H, Hutter C: Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumonology Task Group on BAL. Eur Respir J 1990;3:937-974.
6. American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
7. Reynolds HY: Use of bronchoalveolar lavage in humans: past necessity and future imperative. Lung 2000;178:271-293.
8. Ward K, O'Connor C, Odlum C, et al: Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989;44:6-12.
9. Verstraeten A, Demedts M, Verwilghen J, et al: Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 1990;98:560-567.
10. Fireman E, Vardinon N, Burke M, et al: Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 1998;11:706-711.
11. Drent M, Jacobs JA, de Vries J, et al: Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13:1338-1344.
12. du Bois RM: Diffuse lung disease: a view for the future. Sarcoidosis Vasc Diffuse Lung Dis 1997;14:23-30.
13. The BAL Cooperative Group Steering Committee: Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141:S169-S202.
14. Drent M, van Nierop MA, Gerritsen FA, et al: A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996;153:736-741.
15. Haslam PL, Baughman RP: Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL (editorial). Eur Respir J 1999;14:245-248.
16. Klech H, Pohl WV: Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989;2:561-585.
17. Garcia JG, Wolven RG, Garcia PL, et al: Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 1986;133:444-449.
18. De Brauwer E, Jacobs J, Nieman F, et al: Test characteristics of acridine orange, Gram, and May-Grünwald-Giemsa stains for enumeration of intracellular organisms in bronchoalveolar lavage fluid. J Clin Microbiol 1999;37:427-429.
19. Baughman RP, Dohn MN, Frame PT: The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994;97:515-522.
20. Drent M, van Velzen Blad H, Diamant M, et al: Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993;104:795-800.
21. Drent M, Grutters JC, Mulder PG, et al: Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Sarcoidosis Vasc Diffuse Lung Dis 1997;14:31-38.
22. Kantrow SP, Meyer KC, Kidd P, et al: The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10:2716-2721.
23. Agostini C, Trentin L, Zambello R, et al: CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. Am J Med 1993;95:466-472.
24. Ando M, Konishi K, Yoneda R, et al: Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol 1991;87:1002-1009.
25. Drent M, van Velzen Blad H, Diamant M, et al: Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 1993;6:1276-1281.
26. Welker L, Jorres RA, Costabel U, et al: Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-1006.
27. Keicho N, Oka T, Takeuchi K, et al: Detection of lymphomatous involvement of the lung by bronchoalveolar lavage: application of immunophenotypic and gene rearrangement analysis. Chest 1994;105:458-462.
28. Nehashi Y, Nakano M, Utsumi K, et al: Primary pulmonary B-cell lymphoma diagnosed by kappa-lambda imaging of bronchoalveolar lavage fluid lymphocytes. Intern Med 1993;32:480-483.
29. Jacobs JA, De Brauwer EI, Ramsay G, et al: Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology. Respir Med 1999;93:571-578.
30. Costabel U, Guzman J: Alveolar proteinosis. Eur Resp Monogr 2000;14:194-205.
31. Daniele RP, Elias JA, Epstein PE, et al: Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med 1985;102:93-108.
32. Costabel U: Atlas of Brochoalveolar Lavage. London, Chapman & Hall, 1998.
33. Costabel U, Guzman J: Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001;7:255-261.
34. Costabel U: CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J 1997;10:2699-2700.
35. Cormier Y, Belanger J, Laviolette M: Persistent bronchoalveolar lymphocytosis in asymptomatic farmers. Am Rev Respir Dis 1986;133:843-847.
36. Laviolette M, Cormier Y, Loiseau A, et al: Bronchoalveolar mast cells in normal farmers and subjects with farmer's lung: diagnostic, prognostic, and physiologic significance. Am Rev Respir Dis 1991;144:855-860.
37. Schnabel A, Reuter M, Gloeckner K, et al: Bronchoalveolar lavage cell profiles in Wegener's granulomatosis. Respir Med 1999;93:498-506.
38. Camus P, Colby TV: The lung in inflammatory bowel disease. Eur Respir J 2000;15:5-10.
39. Drent M, van Velzen Blad H, Diamant M, et al: Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid. Chest 1993;103:1720-1724.
40. Nagai S, Kitaichi M, Itoh H, et al: Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP (see comments). [Published erratum appears in Eur Respir J 1999;13:711.] Eur Respir J 1998;12:1010-1019.
41. Drent M, Jacobs JA, Cobben NA, et al: Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release. Respir Med 2001;95:781-786.
42. Djamin RS, Drent M, Schreurs AJ, et al: Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients: bronchoalveolar lavage vs. bronchial brushing. Acta Cytol 1998;42:933-938.
43. Cobben NA, Jacobs JA, van Dieijen Visser MP, et al: Diagnostic value of BAL fluid cellular profile and enzymes in infectious pulmonary disorders. Eur Respir J 1999;14:496-502.
44. Raghu G, Meyer KC: American Thoracic Society Task Force on the Use of Bronchoalveolar Lavage in Evaluation of Interstial Lung Disease (in preparation).
45. Allen JN, Davis WB: Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423-1438.
46. Newman Taylor A: Pulmonary eosinophilia: the eosinophilic pneumonias; in Olivieri D, du Bois RM (eds): Interstitial Lung Diseases. Sheffield, European Respiratory Monograph, 2000, chap 213, pp 206-225.
47. Jacobs JA, Dieleman MM, Cornelissen EI, et al: Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia. Acta Cytol 2001;45:317-326.
48. Cordier JF: Pulmonary vasculitis. Rev Med Interne 2002;23(suppl 5):547s-548s.
49. Pesci A, Bertorelli G, Gabrielli M, et al: Mast cells in fibrotic lung disorders. Chest 1993;103:989-996.
50. Costabel U, Uzaslan E, Guzman J: Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004;25:25-35.
51. Camus P, Foucher P, Bonniaud P, et al: Drug-induced infiltrative lung disease. Eur Respir J 2001;18:93s-100s.
52. Israel Biet D, Labrune S, Huchon GJ: Drug-induced lung disease: 1990 review. Eur Respir J 1991;4:465-478.
53. Linssen KC, Jacobs JA, Poletti VE, et al: Reactive type II pneumocytes in bronchoalveolar lavage fluid. Acta Cytol 2004;48:497-504.
54. Bonaccorsi A, Cancellieri A, Chilosi M, et al: Acute interstitial pneumonia: report of a series. Eur Respir J 2003;21:187-191.
55. Hunninghake GW, Zimmerman MB, Schwartz DA, et al: Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-196.
56. Lynch DA, David Godwin J, Safrin S, et al: High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488-493.